Meeting Banner
Abstract #1737

Dynamic Contrast Enhanced Imaging in Breast Cancer at 3 and 7 Tesla a Comparison.

Stephan Gruber1, Matthias Riha1, Lenka Minarikova1, Katja Pinker, Marek Chmelik1, Siegfried Trattnig1, Thomas Helbich, Wolfgang Bogner1, 2

1MRCE, Dept. Radiology, Medical University of Vienna, Vienna, Austria; 2Dept. Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States

Dynamic contrast enhanced imaging (DCE-MRI) is an important tool to detect breast lesions high sensitivity and specificity. In this pilot study we compared DCE-MRI in seven patients with invasive ductal carcinomas at 3 and 7 T. This resulted in bilateral T1w-images with high spatial resolution and good image quality in all patients at both field strengths. The increase in the contrast-to-noise ratio was in average 2.375 times higher at 7T compared to 3T. In addition, the specificity at 7 T was increased. This study suggests that DCE-MRI is possible at 7 Tesla and may further increase diagnostic accuracy in clinical MR imaging of the breast.

Keywords

accuracy addition agent application benign bilateral blue body bolus breast cancer carcinomas clinical coils color combination comparable confirm confirmed contrast coronal currently curve decrease dedicated defined dependence dept detect detection diagnosis diagnostic differentiate dynamic early enhanced enhancement feasible female field fitted fraction general good hand hinder hospital important improve in vivo included indicated indicating inhomogeneities injected intensity intravenously invasive invest isotropic kilogram kinetic lesion lesions location malignant manually material medical monitoring noise patients pilot pinker plotted potential quality radiology reduce resolution resolutions response satisfactory school sensitivity seven spatial specificity staging stark strengths studies subsequently suppression systems temporal therapy translation transversal tumor twist wash whole years